Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031248 | protein acetyltransferase complex | 3 | 10 |
GO:0031414 | N-terminal protein acetyltransferase complex | 4 | 10 |
GO:0031415 | NatA complex | 5 | 10 |
GO:0032991 | protein-containing complex | 1 | 10 |
GO:0140535 | intracellular protein-containing complex | 2 | 10 |
GO:1902493 | acetyltransferase complex | 4 | 10 |
GO:1902494 | catalytic complex | 2 | 10 |
GO:1990234 | transferase complex | 3 | 10 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A0A3S7WSC5
Term | Name | Level | Count |
---|---|---|---|
GO:0006473 | protein acetylation | 6 | 10 |
GO:0006474 | N-terminal protein amino acid acetylation | 5 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0019538 | protein metabolic process | 3 | 10 |
GO:0031365 | N-terminal protein amino acid modification | 5 | 10 |
GO:0036211 | protein modification process | 4 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0043412 | macromolecule modification | 4 | 10 |
GO:0043543 | protein acylation | 5 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0051604 | protein maturation | 4 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0004596 | peptide alpha-N-acetyltransferase activity | 8 | 10 |
GO:0008080 | N-acetyltransferase activity | 6 | 10 |
GO:0016407 | acetyltransferase activity | 5 | 10 |
GO:0016410 | N-acyltransferase activity | 5 | 10 |
GO:0016740 | transferase activity | 2 | 10 |
GO:0016746 | acyltransferase activity | 3 | 10 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 10 |
GO:0034212 | peptide N-acetyltransferase activity | 7 | 10 |
GO:1990189 | peptide-serine-alpha-N-acetyltransferase activity | 9 | 1 |
GO:1990190 | peptide-glutamate-alpha-N-acetyltransferase activity | 9 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.341 |
CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.630 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.367 |
CLV_NRD_NRD_1 | 82 | 84 | PF00675 | 0.319 |
CLV_PCSK_KEX2_1 | 165 | 167 | PF00082 | 0.594 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.739 |
CLV_PCSK_KEX2_1 | 253 | 255 | PF00082 | 0.754 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.367 |
CLV_PCSK_PC1ET2_1 | 165 | 167 | PF00082 | 0.594 |
CLV_PCSK_PC1ET2_1 | 200 | 202 | PF00082 | 0.739 |
CLV_PCSK_PC1ET2_1 | 253 | 255 | PF00082 | 0.754 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 205 | 209 | PF00082 | 0.767 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.403 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.444 |
DOC_ANK_TNKS_1 | 168 | 175 | PF00023 | 0.594 |
DOC_USP7_MATH_1 | 183 | 187 | PF00917 | 0.726 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.664 |
DOC_WW_Pin1_4 | 184 | 189 | PF00397 | 0.664 |
LIG_14-3-3_CanoR_1 | 4 | 9 | PF00244 | 0.412 |
LIG_14-3-3_CanoR_1 | 50 | 54 | PF00244 | 0.416 |
LIG_14-3-3_CanoR_1 | 93 | 97 | PF00244 | 0.341 |
LIG_APCC_ABBA_1 | 120 | 125 | PF00400 | 0.316 |
LIG_Clathr_ClatBox_1 | 222 | 226 | PF01394 | 0.623 |
LIG_eIF4E_1 | 30 | 36 | PF01652 | 0.416 |
LIG_FHA_2 | 5 | 11 | PF00498 | 0.396 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.373 |
LIG_LIR_Nem_3 | 126 | 132 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 37 | 41 | PF02991 | 0.323 |
LIG_SH2_CRK | 107 | 111 | PF00017 | 0.373 |
LIG_SH2_CRK | 33 | 37 | PF00017 | 0.316 |
LIG_SH2_STAT3 | 12 | 15 | PF00017 | 0.398 |
LIG_SH2_STAT3 | 43 | 46 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 160 | 163 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.316 |
LIG_SUMO_SIM_anti_2 | 74 | 81 | PF11976 | 0.316 |
LIG_UBA3_1 | 222 | 230 | PF00899 | 0.683 |
LIG_WRC_WIRS_1 | 148 | 153 | PF05994 | 0.536 |
MOD_CK1_1 | 187 | 193 | PF00069 | 0.660 |
MOD_CK1_1 | 244 | 250 | PF00069 | 0.713 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.675 |
MOD_CK2_1 | 92 | 98 | PF00069 | 0.341 |
MOD_Cter_Amidation | 198 | 201 | PF01082 | 0.730 |
MOD_Cter_Amidation | 251 | 254 | PF01082 | 0.814 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.627 |
MOD_GlcNHglycan | 209 | 213 | PF01048 | 0.670 |
MOD_GlcNHglycan | 243 | 246 | PF01048 | 0.740 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.673 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.567 |
MOD_GSK3_1 | 183 | 190 | PF00069 | 0.643 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.798 |
MOD_N-GLC_1 | 245 | 250 | PF02516 | 0.804 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.440 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.341 |
MOD_PKA_1 | 253 | 259 | PF00069 | 0.752 |
MOD_PKA_1 | 4 | 10 | PF00069 | 0.405 |
MOD_PKA_2 | 112 | 118 | PF00069 | 0.127 |
MOD_PKA_2 | 253 | 259 | PF00069 | 0.794 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.396 |
MOD_PKA_2 | 49 | 55 | PF00069 | 0.416 |
MOD_PKA_2 | 92 | 98 | PF00069 | 0.341 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.543 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.440 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.667 |
MOD_ProDKin_1 | 184 | 190 | PF00069 | 0.665 |
MOD_SUMO_rev_2 | 159 | 167 | PF00179 | 0.503 |
TRG_DiLeu_BaLyEn_6 | 163 | 168 | PF01217 | 0.606 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.347 |
TRG_ENDOCYTIC_2 | 32 | 35 | PF00928 | 0.320 |
TRG_ER_diArg_1 | 3 | 5 | PF00400 | 0.378 |
TRG_Pf-PMV_PEXEL_1 | 20 | 24 | PF00026 | 0.393 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P642 | Leptomonas seymouri | 75% | 98% |
A0A0S4JB69 | Bodo saltans | 65% | 92% |
A0A1X0NPT1 | Trypanosomatidae | 63% | 100% |
A0A3R7M1B7 | Trypanosoma rangeli | 57% | 100% |
A4HDU9 | Leishmania braziliensis | 27% | 100% |
A4HHS3 | Leishmania braziliensis | 93% | 100% |
A4HVG9 | Leishmania infantum | 100% | 100% |
E9AP60 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
P07347 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 40% | 100% |
P36416 | Dictyostelium discoideum | 42% | 100% |
P41227 | Homo sapiens | 48% | 100% |
Q2KI14 | Bos taurus | 48% | 100% |
Q3UX61 | Mus musculus | 49% | 100% |
Q4QGC8 | Leishmania major | 98% | 100% |
Q8LGI8 | Arabidopsis thaliana | 28% | 100% |
Q9BSU3 | Homo sapiens | 47% | 100% |